Dedalus, Ibex Launches AI-powered Digital Pathology Solution for Cancer Diagnosis

Dedalus Group, a leading provider of anatomic pathology information systems in Europe, and Ibex Medical Analytics, a market leader in AI-powered cancer diagnostics, have jointly launched an integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis. The solution, now available in major European markets, integrates Ibex’s Galen™ platform into Dedalus’ Digital Pathology (DP) Solution. This collaboration aims to set a new standard for anatomic pathology lab digitization by utilizing data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses. The joint solution addresses the increasing demand for pathology services driven by the rising number of cancer patients and a global shortage of trained pathologists. Key features include seamless integration, AI-powered findings for prostate, breast, and gastric biopsies, improved accuracy, decision support tools, streamlined reporting, enhanced laboratory efficiency, and increased diagnostic confidence. Dedalus emphasizes its commitment to advancing anatomic pathology and enhancing patient outcomes through this transformative collaboration.